Cost-effectiveness of pan-genotypic direct-acting antiviral regimens for treatment of chronic Hepatitis C in the United States

2019 ◽  
Vol 20 (3) ◽  
pp. 251-257
Author(s):  
Stuart Gordon ◽  
Janet Lee ◽  
Nathaniel Smith ◽  
Douglas Dieterich
Keyword(s):  
United States ◽  
Chronic Hepatitis ◽  
Cost Effectiveness ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
The United States ◽  
Direct Acting Antiviral ◽  
Direct Acting

Cost-effectiveness of combination daclatasvir-sofosbuvir for treatment of genotype 3 chronic hepatitis C infection in the United States

2017 ◽  
Vol 20 (7) ◽  
pp. 692-702 ◽  
Author(s):  
Catherine Saint-Laurent Thibault ◽  
Divya Moorjaney ◽  
Michael L. Ganz ◽  
Bruce Sill ◽  
Shalini Hede ◽  
...  
Keyword(s):  
United States ◽  
Chronic Hepatitis ◽  
Cost Effectiveness ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
The United States ◽  
Hepatitis C Infection ◽  
Genotype 3

Efficacy of Direct‐Acting Antivirals for Chronic Hepatitis C in a Large Cohort of Older Adults in the United States

2019 ◽  
Vol 68 (2) ◽  
pp. 379-387 ◽  
Author(s):  
Calvin Q. Pan ◽  
Vijay Gayam ◽  
Charles Rabinovich ◽  
Milana Normatov ◽  
Bazhena Fidman ◽  
...  
Keyword(s):  
United States ◽  
Older Adults ◽  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
The United States ◽  
Large Cohort ◽  
Direct Acting Antivirals ◽  
Direct Acting
Sign in / Sign up

Export Citation Format

Share Document